Acrospire Investment Management’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-22
| Closed | – | – | 501 |
|
|
2017
Q2 | $0 | Sell |
22
-8,800
| -100% | – | ﹤0.01% | 2267 |
|
|
2017
Q1 | $40K | Sell |
8,822
-13,288
| -60% | -$60.2K | 0.03% | 1133 |
|
|
2016
Q4 | $55K | Buy |
22,110
+18,036
| +443% | +$44.9K | 0.02% | 1336 |
|
|
2016
Q3 | $13K | Sell |
4,074
-66
| -2% | -$211 | 0.01% | 1627 |
|
|
2016
Q2 | $7K | Buy |
+4,140
| New | +$7K | 0.01% | 1809 |
|